Jirapinyo Pichamol, Thompson Christopher C
Division of Gastroenterology, Hepatology and Endoscopy, Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Division of Gastroenterology, Hepatology and Endoscopy, Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Clin Gastroenterol Hepatol. 2017 May;15(5):619-630. doi: 10.1016/j.cgh.2016.10.021. Epub 2016 Oct 28.
Obesity is a worsening pandemic with numerous related comorbid illnesses. Conservative management including lifestyle modification and medications have limited efficacy. In contradistinction, bariatric surgery is effective, however, with substantial cost and non-negligible morbidity and mortality. As such, a small percentage of eligible patients undergo surgery. Over the past decade, endoscopic bariatric and metabolic therapies have been introduced as a less invasive option for the treatment of obesity and its related comorbid illnesses. This article reviews major endoscopic bariatric and metabolic therapies, their surgical analogues, and proposed mechanisms of action. Clinical trial data for each device also are discussed.
肥胖是一种日益严重的流行病,伴有众多相关的合并症。包括生活方式改变和药物治疗在内的保守治疗效果有限。相比之下,减肥手术是有效的,然而,其成本高昂,发病率和死亡率也不容小觑。因此,只有一小部分符合条件的患者接受手术。在过去十年中,内镜减肥和代谢疗法作为治疗肥胖及其相关合并症的一种侵入性较小的选择被引入。本文综述了主要的内镜减肥和代谢疗法、它们的手术类似物以及提出的作用机制。还讨论了每种设备的临床试验数据。